GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicarious Surgical Inc (NYSE:RBOT) » Definitions » ROC %

RBOT (Vicarious Surgical) ROC % : -296.56% (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Vicarious Surgical ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Vicarious Surgical's annualized return on capital (ROC %) for the quarter that ended in Mar. 2025 was -296.56%.

As of today (2025-07-16), Vicarious Surgical's WACC % is 14.24%. Vicarious Surgical's ROC % is -307.81% (calculated using TTM income statement data). Vicarious Surgical earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Vicarious Surgical ROC % Historical Data

The historical data trend for Vicarious Surgical's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicarious Surgical ROC % Chart

Vicarious Surgical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
ROC %
-1,297.20 -933.86 -482.89 -322.65 -294.30

Vicarious Surgical Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -284.63 -328.54 -324.37 -277.87 -296.56

Vicarious Surgical ROC % Calculation

Vicarious Surgical's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2024 is calculated as:

ROC % (A: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2023 ) + Invested Capital (A: Dec. 2024 ))/ count )
=-66.555 * ( 1 - 0% )/( (24.021 + 21.209)/ 2 )
=-66.555/22.615
=-294.30 %

where

Vicarious Surgical's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2025 is calculated as:

ROC % (Q: Mar. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2024 ) + Invested Capital (Q: Mar. 2025 ))/ count )
=-62.988 * ( 1 - 0% )/( (21.209 + 21.27)/ 2 )
=-62.988/21.2395
=-296.56 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2025) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vicarious Surgical  (NYSE:RBOT) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Vicarious Surgical's WACC % is 14.24%. Vicarious Surgical's ROC % is -307.81% (calculated using TTM income statement data). Vicarious Surgical earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Vicarious Surgical ROC % Related Terms

Thank you for viewing the detailed overview of Vicarious Surgical's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicarious Surgical Business Description

Traded in Other Exchanges
N/A
Address
78 Fourth Avenue, Waltham, MA, USA, 02451
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
Executives
Adam David Sachs director, 10 percent owner, officer: President and CEO C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Sammy Khalifa director, 10 percent owner, officer: Chief Technology Officer C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
William John Kelly officer: CFO and Treasurer C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
John Mazzola officer: Chief Operating Officer TRANSMEDICS INC, 200 MINUTEMAN ROAD, ANDOVER MA 01810
June Morris officer: CLO, General Counsel and Sec C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Khosla Ventures Opportunity Ii, L.p. 10 percent owner 2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures Opportunity Associates Ii, Llc 10 percent owner 2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures V, L.p. 10 percent owner 2128 SAND HILL ROAD, MENLO PARK CA 94025
David D Ho director UNIT 1008, 10/F, CHAMPION TOWER, 3 GARDEN ROAD, CENTRAL K3 00000
Philip Liang director C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Brendel Victoria Carr director C/O VICARIOUS SURGICAL, INC., 78 FOURTH AVENUE, WALTHAM MA 02451
Beverly A Huss director C/O ACCURAY INCORPORATED, 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Shrikant Patnaik other: Principal C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Ric Fulop director C/O DESKTOP METAL, INC., 63 THIRD AVENUE, BURLINGTON MA 01803
Barry Stuart Greene 10 percent owner C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451